PCRX
NASDAQPacira BioSciences
$36.39
+11.19 (+44.40%)
Institutional
113.3%
Insider
1.74%
Retail/Other
-15.0%
Shares Outstanding
39.9M
Top Institutional Holders
As of Oct 2026| Holder | Shares | % | Change |
|---|---|---|---|
| BlackRock Inc | 6.7M | 16.9% | -0.3M |
| Vanguard Group Inc | 4.8M | 12.2% | -0.4M |
| Doma Perpetual Capital Management LLC | 2.8M | 7.0% | - |
| Vanguard Portfolio Management, LLC | 2.5M | 6.3% | +2.5M |
| Dimensional Fund Advisors, Inc. | 2.1M | 5.3% | +0.0M |
| D. E. Shaw & Co LP | 2.0M | 4.9% | -0.0M |
| State Street Corp | 1.9M | 4.8% | +0.0M |
| Renaissance Technologies Corp | 1.8M | 4.6% | -0.1M |
| Vanguard Capital Management, LLC | 1.8M | 4.5% | +1.8M |
| The Goldman Sachs Group Inc | 1.6M | 3.9% | +0.3M |
Insider Transactions
Last 24 months (15 insiders)
Frank D. Lee
Chief Executive Officer
660,830 shares
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 261,818 | - | $5,689,305* | 2026-02-11 | 660,830 |
| 350,000 | - | $9,012,500* | 2025-02-01 | 448,409 |
Jonathan Slonin
Chief Medical Officer
216,383 shares
Sales (4)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 3,040 | $23.23 | $70,619 | 2026-08-17 | 216,383 |
| 3,261 | $22.82 | $74,416 | 2026-03-17 | 223,640 |
| 3,960 | $24.09 | $95,396 | 2025-11-17 | 178,367 |
| 879 | $18.40 | $16,174 | 2025-01-06 | 93,443 |
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 54,546 | - | $1,185,285* | 2026-02-11 | 226,901 |
| 93,600 | - | $2,410,200* | 2025-02-01 | 187,043 |
Kristen Williams
Chief Administrative Officer
185,849 shares
Sales (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 13,137 | $20.53 | $269,703 | 2026-02-02 | 131,303 |
| 14,376 | $26.24 | $377,226 | 2025-06-04 | 161,574 |
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 54,546 | - | $1,185,285* | 2026-02-11 | 185,849 |
| 79,200 | - | $2,039,400* | 2025-02-01 | 182,112 |
Daryl Gaugler
Chief Operating Officer
115,443 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 500 | $19.76 | $9,880 | 2024-12-13 | 115,199 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 243 | $16.01 | $3,900 | 2024-12-31 | 115,443 |
Shawn Cross
Chief Financial Officer
105,341 shares
Sales (6)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 1,500 | $25.01 | $37,515 | 2026-04-22 | 105,341 |
| 2,845 | $25.01 | $71,153 | 2026-04-21 | 105,341 |
| 7,714 | $25.14 | $193,930 | 2026-04-20 | 105,341 |
| 9,104 | $25.14 | $228,875 | 2025-12-10 | 56,250 |
| 15,896 | $25.03 | $397,877 | 2025-12-09 | 56,250 |
| 12,060 | $22.09 | $266,405 | 2025-11-10 | 56,250 |
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 49,091 | - | $1,066,747* | 2026-02-11 | 105,341 |
| 75,000 | - | - | 2024-11-01 | 75,000 |
Brendan Teehan
Chief Commercial Officer
100,934 shares
Awards (3)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 51,714 | - | $1,123,745* | 2026-02-11 | 100,934 |
| 402 | $10.76 | $4,330 | 2025-12-31 | 54,402 |
| 54,000 | - | $1,390,500* | 2025-02-01 | 54,000 |
Lauren Riker
Senior Vice President, Finance
71,586 shares
Sales (3)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,000 | $20.81 | $83,240 | 2026-02-02 | 52,313 |
| 1,416 | $24.24 | $34,324 | 2026-01-05 | 59,064 |
| 5,578 | $26.21 | $146,208 | 2025-06-04 | 59,564 |
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 19,273 | - | $418,802* | 2026-02-11 | 71,586 |
| 30,600 | - | $787,950* | 2025-02-01 | 68,516 |
Mark A. Kronenfeld
Director
31,065 shares
Awards (2)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | - | 2025-06-11 | 31,065 |
| 9,999 | - | $257,474* | 2025-06-11 | 34,901 |
Laura Brege
Director
23,715 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 23,715 |
Mark Froimson
Director
20,136 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 500 | $21.81 | $10,905 | 2026-03-17 | 20,136 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 20,636 |
Christopher Christie
Director
16,654 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 16,654 |
Michael J. Yang
Director
13,393 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 13,393 |
Alethia Young
Director
11,393 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 11,393 |
Marcelo Bigal
Director
11,393 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,912 | $23.67 | $116,267 | 2025-08-07 | 11,393 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 16,305 |
Abraham Ceesay
Director
9,039 shares
Sales (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 2,354 | $27.19 | $64,005 | 2025-09-04 | 9,039 |
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 6,163 | - | $158,697* | 2025-06-11 | 11,393 |
Insider Activity Summary
Last 24 monthsTotal Bought
0 shares
$0
Total Sold
107,032 shares
$2,564,119
Net Shares
-107,032
Net Value
$-2,564,119
Activity by Insider
| Name | Bought | Sold | Net Shares | Net Value |
|---|---|---|---|---|
|
Shawn Cross
Chief Financial Officer
|
- | -49,119 | -49,119 | $-1,195,755 |
|
Kristen Williams
Chief Administrative Officer
|
- | -27,513 | -27,513 | $-646,929 |
|
Jonathan Slonin
Chief Medical Officer
|
- | -11,140 | -11,140 | $-256,605 |
|
Lauren Riker
Senior Vice President, Finance
|
- | -10,994 | -10,994 | $-263,772 |
|
Marcelo Bigal
Director
|
- | -4,912 | -4,912 | $-116,267 |
|
Abraham Ceesay
Director
|
- | -2,354 | -2,354 | $-64,005 |
|
Daryl Gaugler
Chief Operating Officer
|
- | -500 | -500 | $-9,880 |
|
Mark Froimson
Director
|
- | -500 | -500 | $-10,905 |
Net insider selling: 107,032 shares ($2,564,119) in last 12 months
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.